Rami Moucari
Overview
Explore the profile of Rami Moucari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
963
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Issa I, Moucari R
World J Gastroenterol
. 2014 Dec;
20(47):17788-95.
PMID: 25548477
Probiotics use has increased tremendously over the past ten years. This was coupled with a surge of data relating their importance in clinical practice. Antibiotic-associated diarrhea, whose frequency has risen...
2.
Marcellin P, Bonino F, Yurdaydin C, Hadziyannis S, Moucari R, Kapprell H, et al.
Hepatol Int
. 2013 Mar;
7(1):88-97.
PMID: 23518903
Purpose: To investigate the durability of response to peginterferon alfa-2a up to 5 years post-treatment and factors associated with response in hepatitis B e-antigen (HBeAg)-negative patients. Methods: HBeAg-negative patients received...
3.
El Ray A, Asselah T, Moucari R, El Ghannam M, Taha A, Saber M, et al.
Eur J Gastroenterol Hepatol
. 2013 Mar;
25(4):421-7.
PMID: 23470266
Background And Aims: The role of insulin resistance (IR) in chronic hepatitis C genotype 4 (CHC-4) patients is still under assessment. The aims of this study are to assess the...
4.
Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, et al.
Antivir Ther
. 2012 Jan;
17(1):61-70.
PMID: 22267470
Background: Among 141 HIV-HBV-coinfected patients treated with tenofovir in our centre, 87% were good-responders to therapy. Seven patients showed a delayed response to tenofovir. The present study was performed to...
5.
Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, et al.
Liver Int
. 2011 Nov;
32(1):93-101.
PMID: 22097898
Aim: To evaluate the early virological response (EVR) to combined tenofovir-lamivudine or emtricitabine regimen in HBV/HIV-co-infected patients and the long-term efficacy of tenofovir. Methods: In this retrospective monocentric study, among...
6.
Moucari R, Marcellin P
Liver Int
. 2011 Jan;
31 Suppl 1:122-8.
PMID: 21205149
HBsAg is a very important clinical test that might not only indicate active hepatitis B virus (HBV) infection but might also be used to predict clinical and treatment outcome. Clearance...
7.
Rautou P, Douarin L, Denninger M, Escolano S, Lebrec D, Moreau R, et al.
J Hepatol
. 2010 Oct;
54(1):56-63.
PMID: 20889223
Background & Aims: Anticoagulation therapy is recommended for patients with Budd-Chiari syndrome (BCS). This study aimed to assess the incidence, severity, and risk factors of major bleeding in patients with...
8.
Moucari R, Forestier N, Larrey D, Guyader D, Couzigou P, Benhamou Y, et al.
Gut
. 2010 Sep;
59(12):1694-8.
PMID: 20861007
Background/aim: Insulin resistance (IR) is a major predictor of treatment failure in patients with hepatitis C virus (HCV) infection treated with peginterferon/ribavirin. The aim of this study was to evaluate...
9.
10.
Serste T, Nkuize M, Moucari R, Van Gossum M, Reynders M, Scheen R, et al.
Liver Int
. 2010 Jun;
30(8):1131-6.
PMID: 20536721
Background & Aim: Patients with hepatitis C virus (HCV) infection, especially those with genotypes 1 and 4, have an increased risk of developing metabolic disorders. The aim of this study...